Synapse - Matthew O'Brien

Results (20)

Export to EndNote / Excel | PubMed

Mathematical rigor is necessary, but for men with prostate cancer, clinical relevance is the priority - Reply

Journal Article

Vickers, A.; Savage, C.; O'Brien, F.; Lilja, H.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Prostate kallikrein markers in diagnosis, risk stratification and prognosis

Journal Article

Ulmert, D.; O'brien, M. F.; Bjartell, A. S.; Lilja, H.
Nature Reviews Urology (2009)

Fulltext@MSK | Save

The Contribution of Irish Urology to Clinical Practice

Journal Article

O'brien, M. F.; Galvin, D. J.; Mulhall, J. P.
Urology (2009)

Fulltext@MSK | Save

Pretreatment prostate-specific antigen (PSA) velocity and doubling time are associated with outcome but neither improves prediction of outcome beyond pretreatment PSA alone in patients treated with radical prostatectomy

Journal Article

O'brien, M. F.; Cronin, A. M.; Fearn, P. A.; Smith, B.; Stasi, J.; Guillonneau, B.; Scardino, P. T.; Eastham, J. A.; Vickers, A. J.; Lilja, H.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Survival rates after resection for localized kidney cancer: 1989-2004

Meeting Abstract

Jang, T. L.; Pettus, J. A.; Huang, W. C.; Eggener, S. E.; O'Brien, M. F.; Karellas, M. E.; Kagiwada, M. A.; Russo, P.
Journal of Clinical Oncology (2008)

Fulltext@MSK | Save

Long-term prediction of prostate cancer: Prostate-specific antigen (PSA) velocity is predictive but does not improve the predictive accuracy of a single PSA measurement 15 years or more before cancer diagnosis in a large, representative, unscreened population